NasdaqCM - Nasdaq Real Time Price USD
BioCardia, Inc. (BCDA)
1.8300
-0.0300
(-1.61%)
As of 12:33:15 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALLEN JIM L Director | Stock Award(Grant) | Sep 3, 2024 | 109,673 |
| ALTMAN PETER Chief Executive Officer | Purchase | Apr 15, 2025 | 112,720 |
| BLANK ANDREW SCOTT Director | Stock Award(Grant) | Sep 3, 2024 | -- |
| FROST PHILLIP MD ET AL Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 19, 2024 | -- |
| GILLIS EDWARD M Officer | Sale | Dec 20, 2024 | 8,968 |
| MCCLUNG DAVID Chief Financial Officer | Stock Award(Grant) | Oct 11, 2024 | 30,008 |
| STERTZER SIMON H Director | Purchase | Mar 5, 2025 | 138,600 |
Related Tickers
ADXN Addex Therapeutics Ltd
7.60
+4.11%
ADIL Adial Pharmaceuticals, Inc.
0.7010
-3.84%
LIXT Lixte Biotechnology Holdings, Inc.
1.2800
-2.29%
ALZN Alzamend Neuro, Inc.
0.6801
-0.73%
BOLD Boundless Bio, Inc.
1.4800
-6.33%
LRMR Larimar Therapeutics, Inc.
2.3000
+1.77%
CYCN Cyclerion Therapeutics, Inc.
2.8300
-4.07%
QNCX Quince Therapeutics, Inc.
1.0500
-0.94%
AOBI American Oriental Bioengineering, Inc.
0.0005
0.00%
1BT.F Enlivex Therapeutics Ltd.
0.7950
+1.92%